Skip to main content
. 2017 Apr 24;6(4):e005490. doi: 10.1161/JAHA.117.005490

Table 1.

Seriousness Criteria of Clinical Events

Clinical Event Overall, n Serious, n (% of Overall) Hospitalization/Prolongation, n (% of Serious Events) Death, n (% of Serious Events) Life Threatening, n (% of Serious Events) Important Medical Event, n (% of Serious Events) Disability, n (% of Serious Events)
Overall 13 909 3250 (23.4) 2594 (79.9) 321 (9.9) 173 (5.3) 93 (2.9) 38 (1.2)
AEsa 12 743 2276 (17.9) 1839 (80.9) 221 (9.7) 89 (3.9) 78 (3.4) 19 (0.8)
Suspected clinical end points 1166 974 (83.6) 755 (77.6) 100 (10.3) 84 (8.6) 15 (1.5) 19 (2.0)
CEC‐confirmed 769 723 (94.0) 563 (78.0) 69 (9.6) 70 (9.7) 5 (0.7) 15 (2.1)
MI 416 407 (97.8) 309 (76.1) 46 (11.3) 42 (10.3) 1 (0.2) 8 (2.0)
UA 184 175 (95.1) 160 (91.4) 2 (1.1) 9 (5.1) 1 (0.6) 3 (1.7)
Stroke 83 78 (94.0) 49 (62.8) 16 (20.5) 8 (10.3) 1 (1.3) 4 (5.1)
TIMI bleeding, major or minor 86 63 (73.3) 45 (71.4) 5 (7.9) 11 (17.5) 2 (3.2) 0 (0)
CEC‐negated 397 251 (63.2) 192 (76.5) 31 (12.4) 14 (5.6) 10 (4.0) 4 (1.6)
MI or UA 251 181 (72.4) 143 (79.0) 25 (13.8) 7 (3.9) 4 (2.2) 2 (1.1)
Stroke 38 31 (81.6) 18 (58.1) 4 (12.9) 4 (12.9) 3 (9.7) 2 (6.5)
TIMI bleeding, major or minor 108 39 (36.1) 31 (79.5) 2 (5.1) 3 (7.7) 3 (7.7) 0 (0)

AE indicates adverse event; CEC, clinical events classification committee; MI, myocardial infarction; TIMI, Thrombolysis in Myocardial Infarction; UA, unstable angina.

a

Includes the bleeds that were sent only for coordinator‐level review. Three serious AEs and 1 serious end point did not provide a cause. Twenty‐two serious AEs were cancer.